Radiopharm Appoints New Director, No Securities Held
Company Announcements

Radiopharm Appoints New Director, No Securities Held

Radiopharm Theranostics Limited (AU:RAD) has released an update.

Radiopharm Theranostics Limited has announced the appointment of Mr. Noel Donnelly as a director of the company as of October 1, 2024. According to the Initial Director’s Interest Notice provided to the ASX, Mr. Donnelly currently holds no securities in the company. This notice complies with listing rule 3.19A.1 and section 205G of the Corporations Act.

For further insights into AU:RAD stock, check out TipRanks’ Stock Analysis page.

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App